12-month effect of middle ear pressure therapy with the EFET01 device for intractable definite Meniere's disease and delayed endolymphatic hydrops after certification by the public health insurance system in Japan.
Acta Otolaryngol
; 142(6): 491-498, 2022 Jun.
Article
in En
| MEDLINE
| ID: mdl-35723676
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Endolymphatic Hydrops
/
Meniere Disease
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
Acta Otolaryngol
Year:
2022
Document type:
Article
Affiliation country:
Japan